The measurement of complement fragments in clinical disease

This publication has 18 references indexed in Scilit:

• Complement activation products in idiopathic pulmonary fibrosis: Relevance of fragment Ba to disease severity
  Clinical Immunology and Immunopathology, 1990
• Accumulation of anaphylatoxins and terminal complement complexes in inflammatory fluids
  Journal of Internal Medicine, 1990
• C4a anaphylatoxin levels as an indicator of disease activity in systemic lupus erythematosus
  Clinical and Experimental Immunology, 1990
• Comparative study of assays detecting complement activation. Complement-split product C3d (rocket immuno-electrophoresis) and C3d neodeterminants (ELISA)
  Scandinavian Journal of Clinical and Laboratory Investigation, 1990
• Complement: A brief review
  Journal of Allergy and Clinical Immunology, 1989
• Review: assessment of complement activation in clinical immunology laboratories: time for reappraisal?
  Journal of Clinical Pathology, 1989
• Complement Split Products and the Pathogenesis of SLE
  Hospital Practice, 1988
• The terminal complement complex, c5b–9, a marker of disease activity in patients with systemic lupus erythematosus
  Arthritis & Rheumatism, 1988
• Disease-associated loss of erythrocyte complement receptors (CR1, C3b receptors) in patients with systemic lupus erythematosus and other diseases involving autoantibodies and/or complement activation.
  The Journal of Immunology, 1985
• Activation of the fourth component of complement (C4): assessment by rocket immunoelectrophoresis and correlation with the metabolism of C4.
  The Journal of Immunology, 1980